Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

01/08/2025 04:00

Aug 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              127.54              117.68           490.00    
                   (+8.4 pct)          (-1.9 pct)       (+0.6 pct)  
  Operating           22.00               30.69            85.00    
                   (-28.3 pct)         (-25.8 pct)      (+42.3 pct) 
  Pretax              22.65               33.31            85.00    
                   (-32.0 pct)         (-21.4 pct)      (+43.3 pct) 
  Net                 17.67               24.79            67.00    
                   (-28.7 pct)         (-22.1 pct)      (+33.9 pct) 
  EPS Basic         37.62 yen           52.79 yen       142.62 yen  
  EPS Diluted       37.58 yen           52.75 yen                   
  Ann Div                               80.00 yen        80.00 yen  
  -Q2 Div                               40.00 yen        40.00 yen  
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T